Mucopolysaccharidosis clinical trials at UCLA
3 in progress, 1 open to eligible people
ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
open to eligible males ages up to 6 years
The main aim of this study is to evaluate the ability of a prophylactic immune tolerizing regimen (ITR) to prevent or reduce the development of high titer anti-idursulfase antibodies in treatment-naïve participants with Hunter syndrome. In this open …
Torrance, California and other locations
Cannabidiol in Sanfilippo Syndrome
Sorry, not yet accepting patients
The goal of this clinical trial is to test cannabidiol in Sanfilippo syndrome. The main questions it aims to answer are: 1) determine the safety of cannabidiol in Sanfilippo syndrome, and 2) explore the efficacy of cannabidiol in treating the…
Torrance, California
Adalimumab in MPS I, II, and VI
Sorry, in progress, not accepting new patients
Randomized, double-blind, placebo-controlled, parallel-group, single-center study followed by open-label phase, to evaluate the effects of adalimumab compared to placebo on the change from baseline in joint and skeletal disease in children and…
Torrance, California
Our lead scientists for Mucopolysaccharidosis research studies include Lynda Polgreen.
Last updated: